Careers  |  Sign In  |  Register  |   Twitter

Latest in Hematology-Oncology

For diagnosis 1 year after sample collection, the test detected mutations in 90% of patients.
The recurrence rate for cystectomy was 38% compared to 59% for TMT.
Bladder, lung, and skin cancer patients frequently showed evidence of high tumor mutational burden.